RAC1 has been explored as a prognostic marker in HCC, and the Tiam1-Rac1 pathway significantly influences tumor progression in HCC.[17] The RAS family, which includes NRAS, consists of oncogenes that are most frequently mutated in cancers. This evidence concerns the gene TIAM1 and hepatocellular carcinoma.